Impact of Age, Multimorbidity and Frailty on the Prescription of Preventive Antiplatelet Therapy in Older Population

Platelet aggregation inhibitors (PAI) have widely proven their efficiency for the prevention of ischemic cardiovascular events. We aimed to describe PAI prescription in an elderly multimorbid population and to determine the factors that influence their prescription, including the impact of age, como...

Descripción completa

Detalles Bibliográficos
Autores principales: Laborde, Caroline, Barben, Jérémy, Mihai, Anca-Maria, Nuss, Valentine, Vovelle, Jérémie, d’Athis, Philippe, Jouanny, Pierre, Putot, Alain, Manckoundia, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344555/
https://www.ncbi.nlm.nih.gov/pubmed/32599756
http://dx.doi.org/10.3390/ijerph17124541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344555/
https://www.ncbi.nlm.nih.gov/pubmed/32599756
http://dx.doi.org/10.3390/ijerph17124541

Ejemplares similares